Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), bought 30,000 shares at $1.15 ($35K) on 2020-06-05, disclosed to the SEC on 2020-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.15 | 20,000 | $23K | 66.5% |
| 2 | $1.16 | 10,000 | $12K | 33.5% |
| Total | $1.15 avg | 30,000 | $35K | 100% |
| Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |
| TXMD | BUY | 2019-08-12 | $310K | — | Filing → |